SCHEMBL4475724

SCHEMBL4475724

OCCCCCC1CCSS1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.59
KMT2A Q03164 2/20 0.59
TARDBP Q13148 2/20 0.59
CYP2C9 P11712 1/20 0.59
MEN1 O00255 1/20 0.59
NR1I2 O75469 1/20 0.59
ALDH1A1 P00352 1/20 0.59
LMNA P02545 1/20 0.59
POLB P06746 1/20 0.59
THRB P10828 1/20 0.59
TSHR P16473 1/20 0.59
ACHE P22303 1/20 0.59
APEX1 P27695 1/20 0.59
RECQL P46063 1/20 0.59
BLM P54132 1/20 0.59
PMP22 Q01453 1/20 0.59
TDP1 Q9NUW8 1/20 0.59
SAE1 Q9UBE0 1/20 0.59
UBA2 Q9UBT2 1/20 0.59
L3MBTL1 Q9Y468 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24071234 1.00 HSD17B10 (0.59) HSD17B10KMT2ATARDBPCYP2C9MEN1
SCHEMBL7530608 1.00 HSD17B10 (0.59) HSD17B10KMT2ATARDBPCYP2C9MEN1
SCHEMBL26728602 1.00 HSD17B10 (0.59) HSD17B10KMT2ATARDBPCYP2C9MEN1
SCHEMBL26728759 1.00 HSD17B10 (0.59) HSD17B10KMT2ATARDBPCYP2C9MEN1
SCHEMBL4475727 1.00 HSD17B10 (0.59) HSD17B10KMT2ATARDBPCYP2C9MEN1
SCHEMBL26728614 0.98 HSD17B10 (0.61) HSD17B10KMT2ATARDBPCYP2C9MEN1
SCHEMBL16312506 0.98 HSD17B10 (0.61) HSD17B10KMT2ATARDBPCYP2C9MEN1
SCHEMBL29263924 0.87 HSD17B10 (0.67) HSD17B10KMT2ATARDBPCYP2C9MEN1
SCHEMBL30508486 0.82
SCHEMBL30388595 0.82 ACHE (0.50) HSD17B10KMT2ATARDBPCYP2C9MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118271615-A Sulfur-containing polymer-based optical material with high light transmittance, high refraction and low dispersion and preparation method thereof 常州汉韦聚合物有限公司 2024-07-02 CN claimed
US-20230225952-A1 ADDITIVES FOR COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. 2023-07-20 US claimed
EP-3989920-A1 ADDITIVES FOR COLORING AGENTS AND METHODS OF USE THEREOF Living Proof, Inc. (US) 2022-05-04 EP claimed
CN-114222555-A Additives for colorants and methods of use thereof 生活实验公司 2022-03-22 CN claimed
WO-2020264257-A1 ADDITIVES FOR COLORING AGENTS AND METHODS OF USE THEREOF LIVING PROOF, INC. (US) 2020-12-30 WO claimed
EP-3755302-A1 COVALENT TREATMENT WITH THIOLS OF KERATIN-CONTAINING MATERIALS Living Proof, Inc. (US) 2020-12-30 EP claimed
CN-112040926-A Covalent treatment of keratin-containing materials with thiols 生活实验公司 2020-12-04 CN claimed
WO-2019164841-A1 COVALENT TREATMENT WITH THIOLS OF KERATIN-CONTAINING MATERIALS LIVING PROOF, INC. (US) 2019-08-29 WO claimed
US-12622858-B2 Additives for coloring agents and methods of use thereof LIVING PROOF, INC. (US) 2026-05-12 US disclosed
US-20240368352-A1 METHODS AND COMPOSITIONS COMPRISING CHAIN TRANSFER AGENTS IN ABSORBABLE PHOTOPOLYMERIZABLE FORMULATIONS POLY MED INC (US) 2024-11-07 US disclosed
CN-118271615-A Sulfur-containing polymer-based optical material with high light transmittance, high refraction and low dispersion and preparation method thereof 常州汉韦聚合物有限公司 2024-07-02 CN disclosed
CN-112040926-B Covalent treatment of keratin-containing materials with thiols 生活实验公司 2024-07-02 CN disclosed
EP-4363225-A1 METHODS AND COMPOSITIONS COMPRISING CHAIN TRANSFER AGENTS IN ABSORBABLE PHOTOPOLYMERIZABLE FORMULATIONS Poly-Med Inc. (US) 2024-05-08 EP disclosed
CN-117715760-A Compositions and methods comprising chain transfer agents in absorbable photopolymerizable formulations 聚合-医药有限公司 2024-03-15 CN disclosed
EP-1010698-A1 1,2-dithiolane derivatives, their process of preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 2000-06-21 EP disclosed
CN-1257072-A Novel 1,2-amylic cycle disulfide, its preparation process and medicinal compoisitions containing same ADIR (FR) 2000-06-21 CN disclosed
EP-0984928-A1 AROMATIC AND HETEROCYCLIC NITRATO DERIVATIVES YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2000-03-15 EP disclosed
US-6013663-A CATARACT THERAPY OR PREVENTION SANKYO COMPANY, LIMITED (JP) 2000-01-11 US disclosed
EP-0869126-A1 Dithiolan derivatives, their preparation and their therapeutic effect Sankyo Company Limited (JP) 1998-10-07 EP disclosed
WO-1998042661-A1 AROMATIC AND HETEROCYCLIC NITRATO DERIVATIVES YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 1998-10-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12622858-B2 Additives for coloring agents and methods of use thereof SLC25A20, NDUFA10, GAPDH HSD17B10 160/4885KMT2A 3104/4885TARDBP 4144/4885
US-20230225952-A1 ADDITIVES FOR COLORING AGENTS AND METHODS OF USE THEREOF COXFA4L2, TYR, OAT HSD17B10 551/4885KMT2A 1779/4885TARDBP 3141/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.